ClinicalTrials.govpublic full text
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
pharmacokinetics, pharmacodynamics, insulin aspart, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909713
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.